Riluzole in Huntington's Disease
NCT00277602
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
537
Enrollment
INDUSTRY
Sponsor class
Conditions
Huntington Disease
Interventions
DRUG:
Riluzole
Sponsor
Sanofi